Abdominal Massage for Chemotherapy-Induced Constipation
Prevention of Constipation in Cancer Patients
Recruiting
N/AInterventional Study
Constipation Drug Induced
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
Ready to participate?
Review the details below, then apply to join this clinical trial.
At a Glance
Age
18 and older
Sex
Any
Study type
Interventional
Purpose
Prevention
Participants needed
146 (estimated)
Sponsor
Marmara University · Other
Who this trial is looking for
This trial is looking for adults with breast or lung cancer who are experiencing constipation from chemotherapy. Participants will be involved in treatments that aim to reduce constipation symptoms.
Are You a Good Fit for This Trial?
You may be able to join if
I am 18 years of age or older
I am receiving chemotherapy for breast cancer or lung cancer
I have had at least one cycle of chemotherapy
I have experienced constipation related to chemotherapy in the last five days
I can read and write and am willing to take part
I do not have a psychiatric illness
I do not have an abdominal obstruction
I do not have any mass in my abdominal region
You may not be able to join if
I have stool type 3, 4, 5, 6, or 7 according to the Bristol Stool Scale
I have intestinal bleeding
I have had radiation therapy to my abdominal region
I have had surgical procedures in my abdominal region
I have an intra-abdominal infection
I have inflammatory bowel disease
I have irritable bowel syndrome
Summarized in plain language from this trial's official eligibility criteria.
The full criteria are further down this page — only the research team can
confirm whether you qualify.
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Constipation is the third most common symptom in patients undergoing chemotherapy, with an incidence rate ranging from 31% to 90%. Despite its high prevalence and adverse effects on patients, constipation is often not reported by patients and is not frequently monitored by nurses, resulting in delays in treatment and care. Prolonged constipation can lead to health problems such as fecal impaction/…
Constipation is the third most common symptom in patients undergoing chemotherapy, with an incidence rate ranging from 31% to 90%. Despite its high prevalence and adverse effects on patients, constipation is often not reported by patients and is not frequently monitored by nurses, resulting in delays in treatment and care. Prolonged constipation can lead to health problems such as fecal impaction/obstruction, hemorrhoids, rectal pain, and intestinal perforation, thereby reducing patients' quality of life. Additionally, increased severity of constipation in cancer patients may lead to the interruption or complete cessation of chemotherapy. Therefore, it is essential to monitor and assess patients for the risk of developing constipation and to implement an effective nursing care protocol.
Abdominal massage is an approach that increases peristalsis, i.e., digestive system movement, by altering intra-abdominal pressure, thereby reducing the severity of constipation.
Trial Locations
Loading…
Loading trial locations…
Facility
City
State
Country
Status
Eligibility Criteria
Inclusion Criteria:
* 18 years of age or older,
* Receiving chemotherapy for breast cancer or lung cancer that causes constipation
* Patients who received at least one cycle of chemotherapy and experienced chemotherapy-associated constipation within five days of treatment (stool type 1 or 2 accordi…
Inclusion Criteria:
* 18 years of age or older,
* Receiving chemotherapy for breast cancer or lung cancer that causes constipation
* Patients who received at least one cycle of chemotherapy and experienced chemotherapy-associated constipation within five days of treatment (stool type 1 or 2 according to the Bristol Stool Scale)
* Volunteers who are willing to participate in the research, can communicate, and can read and write,
* Without psychiatric illness and abdominal obstruction,
* No mass in the abdominal region was detected,
* No intestinal bleeding,
* No history of radiation therapy to the abdominal region,
* No surgical procedures in the abdominal region,
* Patients without intra-abdominal infection, inflammatory bowel disease and irritable bowel syndrome will be included
Exclusion Criteria:
* Patients with stool type 3, 4, 5, 6 and 7 points according to the Bristol Stool Scale
Picking one helps us show the most relevant trials first.
Your results are loading in the background — you can
change this any time from the results page.
Set your location to continue
Find My Trials uses your location to surface clinical trials near you.
Add your city or zip code to your profile and try again.